The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Pharmacology · Pharmacokinetics

Follow-up: Subcutaneous absorption kinetics and site differences

HC
h.castellanosTL2 Moderator7 Oct 2025#1

Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable.

I would like to understand what this number means before I repeat it anywhere.

A PeptideMeter report on a retatrutide lot gives 98.6% purity. The supplier certificate for the same lot states 97.5%. Both documents name a reversed-phase method; neither states the same gradient.

My question is not "who is right". It is: given that those two figures were produced by different methods, what is the largest difference I should expect from method alone, and at what point does a gap stop being explainable that way?

39 likes 10mo
FP
forest_plotTL3Evidence synthesis8 Oct 2025#2

Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.

9 likes 10mo
NV
n.villalobosTL2 Moderator10 Oct 2025#3

On the opening post — agreed on the reasoning, with one qualification.

Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments might be needed.

2 likes 10mo
BI
blank_injectionTL2Analytical chemist11 Oct 2025#4
n.villalobos, post #3: On the opening post — agreed on the reasoning, with one qualification. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments might be needed. Go to post

post #3 answers the question as asked. The question underneath it is different.

Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to maximise absorption. Violating it measurably reduces exposure.

0 likes in reply to #3 10mo
CM
c.marchettiTL2 Moderator12 Oct 2025#5

SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral bioavailability is too low for clinical use. With it, bioavailability is still variable between people.

15 likes 10mo
Moved from Formulation chemistry by owen.brady. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
AWBWCEAWS+128 139 3k 3mo
Time to steady state after a dose increase
On the subject in the title: Time to steady state after a dose increase Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of me that…
LCKJSLKC+151 163 9.7k 21mo
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. I would like to understand what this number means…
BRIJVPYR+7 11 31k 17mo
Peak-to-trough ratio at steady state for a weekly agent — the long version
Peak-to-trough ratio at steady state for a weekly agent — the long version Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means…
CTRSWAVUC+57 61 708 1d
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
EDRFCHLIAK+110 126 14k 4mo

Related topics — sharing the tags semaglutide, liraglutide, worked example

TopicParticipantsRepliesViewsActivity
Titles that describe the question, not the situation
Titles that describe the question, not the situation — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the things people…
PFCPSIKRZS+139 153 22k 8mo
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
TKNMPMBSMC+74 80 17k 2d
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it before…
SSDSEF 2 45k 5mo
Second pass at: Choosing a concentration on purpose rather than by accident
Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because…
SDNKEARSI+44 48 1k 19mo
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully
Semaglutide versus liraglutide head to head: reading STEP 8 carefully — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in support of a claim…
DYKBFHKVM+1 5 11k 20mo